Q3 Sales Up 7.2%, Guidance Raised as Adjusted EBITDA Climbs 10.9%
VGNT sits 54% above its 52-week low of $26.34 on elevated volume (3.0× avg).
Summary
Versigent posted Q3 net sales of $2,450 million, up 7.2% year-over-year, though adjusted net sales growth was only about 1% once commodity and currency swings are stripped out. Adjusted EBITDA rose 10.9% to $275 million with margin up 40 basis points to 11.2%, while GAAP net income slipped to $102 million from $109 million on higher interest expense from the Q1 2026 debt financing. Adjusted diluted EPS came in at $1.91 versus $1.81 a year ago, and reported EPS was $1.41. Management raised the midpoint and tightened full-year net sales guidance to $9,500-$9,600 million, tightened Adjusted EBITDA to $970-$1,010 million, and lifted the free cash flow range to $275-$325 million from $200-$300 million. The board declared the $0.13 quarterly dividend, and the company booked $2.1 billion of new business in the quarter. The guidance raise and margin expansion are the actionable pieces; the 1% organic growth is the soft spot to weigh against the higher commodity pass-through driving the sales line.
At the time of this announcement, VGNT was trading at $40.69 on NYSE in the Manufacturing sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $26.34 to $50.89. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: BusinessWire.